Avatar photo

Dr. D. Beard

DR. D. BEARD is specialist of Nash Pathology

Type 2 Diabetes, NAFLD, and cardiovascular risk

Patients with T2DM and NAFLD exhibit higher risk of CVD compared with T2DM without NAFLD. In their review, C. Caussy et al. (Hopital Lyon Sud, France) underline that several studies have provided evidence that NAFLD could be an independent cardiovascular risk factor. A potential synergistic increase of cardiovascular risk between...
Read MoreType 2 Diabetes, NAFLD, and cardiovascular risk

The changing global epidemiology of hepatocellular carcinoma

Hepatocellular carcinoma is the fifth and ninth most commonly diagnosed cancer in men and women, respectively, and the fourth leading cause of cancer mortality worldwide. Risk factors for HCC include chronic hepatitis B and hepatitis C, alcohol addiction, metabolic liver disease (particularly non-alcoholic fatty liver disease) and exposure...
Read MoreThe changing global epidemiology of hepatocellular carcinoma

Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease

Physical inactivity and sedentary lifestyle have contributed to the epidemic of obesity and NAFLD. Moreover, NAFLD and sarcopenia have similar pathophysiological profiles. ZM Younossi et al. assessed the association between physical activity, NAFLD, and sarcopenia, and their contributions to mortality, using data from the National Health and Nutrition...
Read MoreContribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease

Vitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

The results of randomized controlled trials (RCTs) investigating supplemental vitamin D on aminotransferases and cardio-metabolic risk factors in subjects with NAFLD have been inconsistent. A meta-analysis of randomized controlled trials by XF Guo et al. (Institute of Nutrition & Health, Qingdao University...
Read MoreVitamin D and non-alcoholic fatty liver disease: a meta-analysis of randomized controlled trials

Prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis

NAFLD and type 2 diabetes are closely associated phenomena. In contrast to the knowledge about NAFLD and type 2 diabetes, there are limited and inconsistent data on NAFLD prevalence in patients with type 1 diabetes mellitus. Type 1 diabetes and type 2 diabetes show major pathophysiological differences but share certain...
Read MorePrevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 1 diabetes mellitus: a systematic review and meta-analysis

Non-alcoholic fatty liver disease modifies serum gamma-glutamyl transferase in cigarette smokers

Serum gamma-glutamyl transferase (GGT) is a marker of oxidative stress, associated with increased cardiovascular risk. The impact of smoking on oxidative stress may be aggravated in individuals with NAFLD. ET Oni et al. (Cardiology Division, Heart and Vascular Institute, Einstein Medical Center, Philadelphia, PA, USA) aimed to...
Read MoreNon-alcoholic fatty liver disease modifies serum gamma-glutamyl transferase in cigarette smokers

Fatty Liver Index: A Hypertension Predictor in a South Korean Cohort

Although there can be common pathogenic mechanisms for NAFLD and hypertension associated with the development of cardiovascular diseases, little data are showing the association between NAFLD and hypertension in a large-scale cohort study. JH Roh et al. (department of cardiology in internal medicine, Chungnam National University Hospital, Daejeon, Korea)...

Read MoreFatty Liver Index: A Hypertension Predictor in a South Korean Cohort

Characterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH

For many years, double-layer phospholipid membrane vesicles, released by most cells, were not considered to be of biological significance. This stance has dramatically changed with the recognition of extracellular vesicles (EVs) as carriers of biologically active molecules that can traffic to local or distant targets and execute defined biological functions...
Read MoreCharacterization and Proteome of Circulating Extracellular Vesicles as Potential Biomarkers for NASH

Left ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis

Cardiovascular death is an important cause of mortality in end stage liver disease patients undergoing orthotopic liver transplant. Left ventricular diastolic dysfunction is often the early manifestation of cirrhotic cardiomyopathy. In order to understand the risk factors for ventricular diastolic dysfunction in end stage liver disease patients...
Read MoreLeft ventricular diastolic dysfunction in liver transplantation: a stronger association with non-alcoholic steatohepatitis

Determining the reliability of liver biopsies in NASH clinical studies

The topic of liver biopsy in clinical studies, such as for treatments for NASH, is highly important. Despite limitations, liver biopsy remains the gold standard for the study of liver disease. It is important for the exclusion of alternative diseases and co-morbidities such as autoimmune hepatitis or primary biliary cholangitis...
Read MoreDetermining the reliability of liver biopsies in NASH clinical studies